Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome

Feb 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G AndreiE De Clercq

Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties

Dec 1, 1990·Diseases of the Colon and Rectum·S D Wexner

Antiviral activity of Bifidobacterium adolescentis SPM 0214 against herpes simplex virus type 1

Oct 12, 2012·Archives of Pharmacal Research·Hyang Mi AnNam Joo Ha

The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice

Aug 1, 1995·Journal of Neuroimmunology·K A HayR B Tenser

Antiviral drug resistance

Aug 1, 1989·Trends in Pharmacological Sciences·H J Field, S E Goldthorpe

A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2

Sep 1, 1994·Journal of Virological Methods·K SudoS Shigeta

The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy.

May 1, 1991·Antiviral Research·D M Coen

Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice

May 1, 1995·Antiviral Research·Y Y LiR Mori

Antiviral resistance in clinical practice

Apr 1, 1995·Antiviral Research·D W KimberlinR J Whitley

A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.

Sep 1, 1992·Virus Research·G PalùA Marcello

Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon)

Apr 1, 1996·Journal of Dermatological Science·J YamamuraK Shiraki

Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation

May 1, 1996·European Journal of Cancer. Part B, Oral Oncology·J B EpsteinD Reece

Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir

Sep 9, 1989·Lancet·H AgutL Montagnier

Establishment and use of a cell line expressing HSV-1 thymidine kinase to characterize viral thymidine kinase-dependent drug-resistance

Jun 14, 2002·Antiviral Research·Jee Hyun KimChong-Kyo Lee

Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain

Oct 31, 2002·Antiviral Research·Masayuki SaijoIchiro Kurane

Management of acyclovir-resistant herpes simplex virus

May 22, 2003·Dermatologic Clinics·Suneel Chilukuri, Ted Rosen

Cutaneous viral infections in HIV-infected individuals

Oct 12, 2000·Clinics in Dermatology·A Yen-MooreS K Tyring

Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice

Dec 1, 1996·Journal of Dermatological Science·Y YoshidaK Shiraki

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Aug 22, 1991·The New England Journal of Medicine·S SafrinJ Mills

Therapy for human immunodeficiency virus infection

Jun 10, 1993·The New England Journal of Medicine·M S Hirsch, R T D'Aquila

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient

Dec 9, 1993·The New England Journal of Medicine·R G KostS E Straus

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate

Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D M CoenD M Knipe

Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D H KatzL R Katz

A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant

Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·C B HwangD M Coen

Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience

Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N RabellaG Prats

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group

Jun 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·H A KesslerJ A Korvick

Genital ulcer disease

Mar 1, 1993·International Journal of Dermatology·H J Engelkens, E Stolz

Perspectives in antiviral chemotherapy

Jan 1, 1990·Fundamental & Clinical Pharmacology·J M HurauxH Agut

Experimental therapy of human glioma by means of a genetically engineered virus mutant

May 10, 1991·Science·R L MartuzaD M Coen

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management

Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Jocelyne Piret, Guy Boivin

2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Aug 22, 2012·Antimicrobial Agents and Chemotherapy·Mårten StrandGöran Wadell

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Nov 1, 1991·Antimicrobial Agents and Chemotherapy·S C StanatK K Biron

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.

Nov 1, 1991·Antimicrobial Agents and Chemotherapy·E L HillM N Ellis

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.

Apr 1, 1991·Antimicrobial Agents and Chemotherapy·E De Clercq, A Holý

Foscarnet alters antidiuretic hormone-mediated transport.

Sep 1, 1995·Antimicrobial Agents and Chemotherapy·B S HochH I Lipner

Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.

Dec 22, 1999·Antimicrobial Agents and Chemotherapy·J PiretM G Bergeron

Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain

Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Masayuki SaijoIchiro Kurane

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Jan 13, 2004·Journal of Clinical Microbiology·C Danve-SzatanekC Zandotti

Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A.

Mar 6, 2012·BMC Bioinformatics·Abhinav GroverDurai Sundar

Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells

Sep 27, 2007·Annals of Clinical Microbiology and Antimicrobials·Manuela SaddiAlessandro De Logu

Current recommendations for the treatment of genital herpes

Jan 11, 2001·Drugs·D T Leung, S L Sacks

Mutation hot spots in the canine herpesvirus thymidine kinase gene

Jun 21, 2005·Virus Genes·Shinya YamadaHaruki Otsuka

Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study

Feb 1, 1995·Immunopharmacology and Immunotoxicology·S MasciG Santini

Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies

Jan 1, 1990·Cancer Investigation·H K HollandR Saral

❮ Previous

Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome

Abstract

References

A rapid technique for distinguishing herpes-simplex virus type 1 from type 2 by restriction-enzyme technology

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome

Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS

DNA restriction enzyme analysis of digital and genital isolates of herpes simplex virus from three patients

Drugs five years later: acyclovir

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child

Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene

The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication

Citations

Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus

Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus

Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir

Demonstration of herpes simplex virus DNA in CSF cells by in situ hybridization for early diagnosis of herpes encephalitis

Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet

Comparative activity of various compounds against clinical strains of herpes simplex virus.